
Hold, $125 target: FY27 is secured, the FY28-FY30 path looks too high
Hold, $125 target: 7.7% upside to target and 9.4% total return. Oracle sells database software and now AI cloud capacity; the shares are down 52% in a year to 9.5x FY27E EBITDA. Our $114 weighted value rolls to the $125 target.
- Backlog converts below plan: FY30E revenue $175bn vs the $225bn target. OpenAI concentration is worth −$32.6 a share (Chapter 10).
- Leases hold infrastructure margin near 60%, not 66%. $288bn of leases start by FY29; one point is $4.04 a share (Chapter 11).
- WACC decides the call: one point is $27.76 a share. Three of four alternative discount-rate tests move the rating; conviction is Low (Chapter 12).
What the market is missing. Our FY28E non-GAAP EPS of $8.29 is 25% below the Street’s $11.05, but the price already implies a 58.9% FY30E infrastructure margin against our 60.0%.
Catalysts. FQ2 FY27 results (Dec 2026); FQ3 RPO update (Mar 2027) decides +$24.3 or −$32.6; FY28 capex guide (Jun 2027).
Valuation and target. Ten-year DCF at 9.8% WACC: base $120.46; EV/EBITDA cross-check $152.52, which ignores $182bn of capex. Bear $26.50 (30%), base $120.46 (50%) and bull $229.80 (20%) weight to $114.14, which rolls to the $125 target.
Risks. OpenAI funding (−$32.6), lease costs (−$20.2), political backlash (−$16.9), funding costs (−$13.2).
| Year to 31 May, US$ | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue ($bn) | 57.4 | 67.4 | 90.2 | 119.3 | 149.1 |
| Growth y/y | 8.4% | 17.4% | 33.9% | 32.3% | 24.9% |
| EBITDA ($bn) | 23.9 | 29.9 | 49.8 | 64.8 | 82.4 |
| Margin | 41.6% | 44.4% | 55.3% | 54.3% | 55.3% |
| Net income ($bn) | 12.4 | 17.1 | 20.5 | 20.7 | 28.1 |
| EPS, GAAP ($) | 4.34 | 5.83 | 6.52 | 6.43 | 8.77 |
| Growth y/y | 17.0% | 34.3% | 11.9% | −1.4% | 36.4% |
| Free cash flow ($bn) | (0.4) | (23.7) | (25.1) | (24.3) | 6.7 |
| At $116.10 | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| P/E | 26.8x | 19.9x | 17.8x | 18.1x | 13.2x |
| EV/EBITDA | 19.8x | 15.8x | 9.5x | 7.3x | 5.7x |
| P/B | 16.3x | 9.0x | 4.1x | 3.4x | 2.6x |
| FCF yield | −0.1% | −6.4% | −6.8% | −6.6% | 1.8% |
| Dividend yield | 1.5% | 1.7% | 1.7% | 1.7% | 1.7% |
| ROE | 85% | 59% | 32% | 21% | 22% |
| Net debt / EBITDA | 3.4x | 3.3x | 2.0x | 2.0x | 1.6x |
| P/E at our $125 target | 28.8x | 21.4x | 19.2x | 19.4x | 14.2x |
Source: Company filings; NYSE closes (Signals, Yahoo Finance; weekly, SPY as S&P 500); Penmark Research model. Shaded = estimates. Multiples at the 6 Nov 2026 close on GAAP EPS (non-GAAP FY27E P/E 14.3x at price, 15.4x at target). FCF includes customer prepayments; net debt excludes finance leases.
Base case is worth $120; the bear case is −77% and the bull case +98% (upside $113.7, downside $89.6)
Source: NYSE closes (Signals, Yahoo Finance); Penmark Research model. Scenario values at 6 Nov 2026 rolled at 9.5% a year (cost of equity less dividend yield).
Management plan on time: FY30E revenue $226bn, infrastructure margin 66%, capex $100bn in FY28E.
FY27E at guidance; FY30E revenue $175bn as OpenAI concentration slows growth; margin 60% as leases start.
OpenAI commitments renegotiated, older capacity churns; margin falls to 52%, FY30E revenue $118bn.
| Income statement, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue | 57.4 | 67.4 | 90.2 | 119.3 | 149.1 |
| EBITDA | 23.9 | 29.9 | 49.8 | 64.8 | 82.4 |
| D&A | (6.2) | (9.3) | (20.0) | (33.7) | (40.2) |
| EBIT | 17.7 | 20.6 | 29.8 | 31.1 | 42.2 |
| Net interest | (3.0) | (3.8) | (5.1) | (5.8) | (7.5) |
| Income taxes | (1.7) | (2.5) | (4.0) | (4.3) | (6.2) |
| Net income, Oracle | 12.4 | 17.1 | 20.5 | 20.7 | 28.1 |
| Net income, common | 12.4 | 17.0 | 20.2 | 20.4 | 27.9 |
| Cash flow, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Operating cash flow | 20.8 | 32.0 | 67.4 | 65.7 | 71.7 |
| Capex | (21.2) | (55.7) | (92.5) | (90.0) | (65.0) |
| FCF, company basis | (0.4) | (23.7) | (25.1) | (24.3) | 6.7 |
| Prepaid, received | 0.0 | 4.6 | 22.5 | 10.0 | 5.0 |
| Prepaid, recognised | 0.0 | 0.0 | 0.0 | (4.1) | (8.3) |
| FCF ex prepayments | (0.4) | (28.3) | (47.6) | (30.2) | 9.9 |
| Dividends | (4.7) | (5.8) | (6.1) | (6.2) | (6.2) |
| Cash, year end | 11.2 | 31.9 | 35.1 | 15.0 | 15.2 |
| Balance sheet, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Cash and securities | 11.2 | 31.9 | 35.1 | 15.0 | 15.2 |
| Net PP&E | 43.5 | 100.0 | 173.5 | 230.7 | 256.2 |
| Total assets | 168.4 | 247.1 | 322.8 | 359.0 | 384.0 |
| Borrowings | 92.6 | 129.5 | 134.5 | 145.2 | 145.2 |
| Customer prepayments | 0.0 | 4.6 | 27.1 | 33.0 | 29.8 |
| Net debt ex leases | 81.4 | 97.6 | 99.4 | 130.2 | 130.1 |
| Total equity | 21.0 | 43.1 | 92.4 | 113.5 | 143.2 |
| Net debt / EBITDA | 3.4x | 3.3x | 2.0x | 2.0x | 1.6x |
| Per share and KPIs | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Diluted shares (m) | 2,866 | 2,914 | 3,093 | 3,175 | 3,175 |
| EPS, GAAP ($) | 4.34 | 5.83 | 6.52 | 6.43 | 8.77 |
| DPS ($) | 1.70 | 2.00 | 2.00 | 2.00 | 2.00 |
| FCF per share ($) | (0.14) | (8.13) | (8.13) | (7.64) | 2.10 |
| BVPS ($) | 7.1 | 12.9 | 28.0 | 33.8 | 44.6 |
| Infra revenue ($bn) | 10.2 | 18.1 | 39.2 | 66.7 | 94.6 |
| Infra % of revenue | 17.8% | 26.9% | 43.5% | 55.8% | 63.5% |
| Capex / revenue | 37% | 83% | 103% | 75% | 44% |
Source: Company filings; Penmark Research model. Year to 31 May; shaded = estimates. GAAP; FCF = operating cash flow less capex; company-basis FCF includes net customer prepayments (received less recognised as revenue). Infra = cloud infrastructure.
Returns fall as capex is depreciated, and the one big gap to the Street is FY28E EPS: $8.29 against $11.05
| Growth, margins | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Growth y/y | |||||
| Sales | 8.4% | 17.4% | 33.9% | 32.3% | 24.9% |
| EBITDA | 11.0% | 25.4% | 66.7% | 30.0% | 27.2% |
| EBIT | 15.1% | 16.6% | 44.7% | 4.2% | 35.7% |
| EPS, GAAP | 17.0% | 34.3% | 11.9% | −1.4% | 36.4% |
| DPS | 6.2% | 17.6% | 0.0% | 0.0% | 0.0% |
| Margins and cover | |||||
| EBITDA margin | 41.6% | 44.4% | 55.3% | 54.3% | 55.3% |
| EBIT margin | 30.8% | 30.6% | 33.1% | 26.1% | 28.3% |
| Net margin | 21.7% | 25.2% | 22.4% | 17.1% | 18.7% |
| FCF margin | −0.7% | −35.2% | −27.9% | −20.3% | 4.5% |
| EBITDA / net interest | 8.0x | 7.8x | 9.8x | 11.2x | 11.0x |
| Ratios and valuation | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Returns and leverage | |||||
| ROE | 85.4% | 58.6% | 32.5% | 21.0% | 22.4% |
| ROA | 8.0% | 8.2% | 7.2% | 6.1% | 7.6% |
| ROCE | 16.9% | 14.4% | 14.9% | 12.8% | 15.4% |
| Net debt / equity, ex leases | 3.9x | 2.3x | 1.1x | 1.1x | 0.9x |
| Net debt / EBITDA, ex leases | 3.4x | 3.3x | 2.0x | 2.0x | 1.6x |
| Valuation at $116.10 | |||||
| P/E, GAAP | 26.8x | 19.9x | 17.8x | 18.1x | 13.2x |
| EV/EBITDA | 19.8x | 15.8x | 9.5x | 7.3x | 5.7x |
| FCF yield | −0.1% | −6.4% | −6.8% | −6.6% | 1.8% |
| Dividend yield | 1.5% | 1.7% | 1.7% | 1.7% | 1.7% |
| P/E at $125 target | 28.8x | 21.4x | 19.2x | 19.4x | 14.2x |
Source: Company filings; Penmark Research model. ROE on average common equity; ROA on average assets; ROCE = EBIT / average (equity + borrowings); net interest = interest expense less interest income. Multiples at the 6 Nov 2026 close; last row at our target. The model does not forecast gross profit, so there is no gross margin row. FY25A DPS from dividends paid. Net debt in these statement tables is borrowings less cash and excludes finance leases ($9.2bn at 31 Aug 2026).
| Year to 31 May | FY27E | FY28E |
|---|---|---|
| Revenue ($bn) | ||
| Penmark estimate | 90.2 | 119.3 |
| Consensus | 90.5 | 131.8 |
| Prior-year period | 67.4 | 90.2 |
| Diff. vs consensus | −0.3% | −9.5% |
| Growth y/y (Penmark) | +33.9% | +32.3% |
| Non-GAAP EPS ($) | ||
| Penmark estimate | 8.11 | 8.29 |
| Consensus | 8.14 | 11.05 |
| Prior-year period | 7.63 | 8.11 |
| Diff. vs consensus | −0.4% | −25.0% |
| Growth y/y (Penmark) | +6.3% | +2.2% |
Source: S&P Global via StockAnalysis (6 Nov 2026); company guidance (FY27 revenue at least $90.0bn, non-GAAP EPS $8.10); Penmark Research model.
| Latest four quarters | ORCL | Peers | Diff. |
|---|---|---|---|
| Valuation | |||
| EV/EBITDA, trailing 4Q | 13.9x | 17.1x | −18.6% |
| Growth and margin | |||
| Revenue growth, latest Q | 29.6% | 19.7% | +9.9pp |
| EBITDA margin, latest Q | 52.1% | 33.9% | +18.2pp |
| Leverage and risk | |||
| Net debt / market value | 0.24x | 0.01x | +0.22x |
| Beta (ORCL relevered) | 1.28x | 1.08x | +0.20x |
Source: Signals and Yahoo Finance prices (6 Nov 2026), company filings; Penmark Research model. Median of six peers (Microsoft, Amazon, Alphabet, Salesforce, CoreWeave, ServiceNow); difference in % for multiples, pp for ratios. Peer beta = median unlevered beta of the four peers with a published beta (Microsoft, Alphabet, Salesforce, CoreWeave).
The shares are cheap on trailing EBITDA and history, but the cheapness is the market pricing capex and funding risk
- Dec 2026FQ2 FY27 results: infrastructure +5pt vs base is worth +$4.0; Microsoft and Tencent churn is −$4.0. We sit on the guide (+30-34% revenue).
- Jan-Feb 2027Hyperscaler CQ4 results: capex staying high keeps compute scarce (+$14.5); not in our base.
- Mar 2027FQ3 FY27 RPO update: conversion of the $664bn backlog (+$24.3) against OpenAI funding (−$32.6).
- Jun 2027FY28 capex guide: $90bn in our base; $15bn lower in FY29 is worth +$4.5.
Source: Company calendar; Penmark Research model catalyst re-runs.
- OpenAI concentration. Largest customer cannot fund its ramp. Likelihood 35%; −$32.6/share.
- Leases ahead of revenue. $288bn of leases commence by FY29. Likelihood 40%; −$20.2/share.
- Political backlash. Post-midterm limits slow data-center capacity. Likelihood 30%; −$16.9/share.
- Funding cost. New notes at 7.00-8.65%; Baa2 outlook negative. Likelihood 30%; −$13.2/share.
- RPO converts on schedule (against our Hold). New contracts on prepaid terms. Likelihood 35%; +$24.3/share.
Source: Penmark Research model; likelihoods are analyst assumptions.
Source: Signals (GAAP diluted EPS), Yahoo Finance prices; Penmark Research. Weekly, Sep 2022 to Nov 2026; trailing four quarters, includes the FQ2 FY26 Ampere gain.
Source: Signals and Yahoo Finance (6 Nov 2026), company filings; Penmark Research. Peers include CoreWeave and ServiceNow, which we do not cover.
| Indicator | Thesis confirmed if | Thesis broken if | Date |
|---|---|---|---|
| Infrastructure revenue growth | FQ2 near +116% y/y run-rate, margin about 60% | Growth below 90% or margin below 55% | Dec 2026 |
| RPO and OpenAI share | RPO above $664bn with prepaid terms | RPO falls or OpenAI commitments are cut | Mar 2027 |
| Funding versus $20bn cap | Prepayments of $22.5bn in FY27E; no new equity | Second equity raise or Moody's to Baa3 or S&P to BB+ | 1H CY27 |
| Capex guide | FY28 at or below $90bn | Above $100bn without new prepaid contracts | Jun 2027 |
| Lease commencement cost | Infrastructure margin holds at 60% | Margin at 52% or lower | FY27-FY28 |
| Cost of capital | WACC near 9.8% | Each +1pt takes value to $90.49 | Ongoing |
Six exhibits carry the thesis: the stock trades on backlog news, and we differ from the Street after FY27
Source: Signals (RPO, prices), Yahoo Finance; Penmark Research. Jun 2025 to Sep 2026; one outlier (FQ1 FY26) drives the fit.
Source: Company filings; Signals; Yahoo Finance (closes at quarter end). RPO $bn: 138, 455, 523, 553, 638, 664.
Source: S&P Global via StockAnalysis (6 Nov 2026); LSEG (FY30); company guidance 10 Sep and 28 Oct 2026; Penmark Research model.
Source: Penmark Research model (6 Nov 2026 prices); S&P Global via StockAnalysis (42 analysts; marker = mean $235.77).
Source: Signals, Yahoo Finance; Penmark Research. Trailing GAAP EPS $4.32 to $6.38; P/E 56.4x to 18.2x; dividends excluded.
Source: Company filings; Penmark Research model. Year to 31 May; FCF includes customer prepayments.
Three debates decide the stock: we are more cautious than the market on backlog and margin, slightly less on the cost of capital
Backlog conversion, infrastructure margin and the cost of capital drive our value for Oracle’s AI build. Backlog and margin resolve by March 2027; the cost of capital swings value by about $58 across a ±1pt range.
| Debate | Market view | Penmark view | Evidence | What would change our view | Resolves |
|---|---|---|---|---|---|
| 1. Backlog conversion | $664bn RPO converts on the management path: FY30E revenue $225bn, FY28E $131.8bn | OpenAI concentration slows it: FY28E infrastructure +70%, FY30E revenue $175bn | OpenAI revenue about $20bn below estimates (8 Oct); Microsoft wind-down; Tencent lease cancelled | RPO above $664bn on prepaid terms (+$24.3 a share) | Mar 2027 |
| 2. Infrastructure margin | 66% FQ1 run-rate holds; group non-GAAP margin 40% by FY30 | 60% as $288bn of leases commence ahead of revenue | FQ1 EBITDA margin 52.1%; gross margin step-down guided; CoreWeave at about 52% | Margin above 63% in two quarters; +$12.1 at +3pt | Dec 2026 |
| 3. Cost of capital | Funding is solved: $20bn cap, about half equity, net debt/EBITDA below 3.5x | Our 9.82% WACC is below the 9.98% the price implies, so we are slightly less cautious; FY28E needs a $10.7bn credit-line draw after the cap | Notes priced 2 Nov at 7.00-8.65%; Moody's Baa2 negative; $29.8bn equity issued | Prepayments above $22.5bn in FY27E; no new equity | 1H 2027 |
Source: Company filings and calls (10 Sep, 28 Oct 2026); S&P Global via StockAnalysis; Penmark Research model.
Source: Penmark Research model; Street-implied infrastructure revenue and the FQ1 FY27 margin run-rate; WACC the price implies (Sensitivities tab).
Source: Company calendar; Penmark Research. Dates for results are estimates until confirmed.
| Debate | Chapter | Stock driver (section 9) | Value at stake, $/share |
|---|---|---|---|
| 1. Backlog conversion | 10 Backlog converts below plan | RPO change on results day | +24.3 / −32.6 |
| 2. Infrastructure margin | 11 Leases hold margin near 60% | Lease cost and GPU pricing | +12.1 / −20.2 |
| 3. Cost of capital | 12 The discount rate decides | Rates and funding cost | −13.2 per +0.5pt |
Source: Penmark Research model catalyst re-runs, 6 Nov 2026.
Cloud is now half of Oracle’s $67.4bn revenue, and 56 cents of each dollar goes to cash operating costs
Source: Company filings and FQ1 FY27 call (10 Sep 2026); Signals; Penmark Research model.
Source: Company filings (10-K FY26); Penmark Research model. Cloud (infrastructure plus applications) is $34.0bn, 50% of revenue. Oracle does not disclose profit or capex by offering.
Source: Company filings; Penmark Research model. Year to 31 May.
Source: Company filings; Penmark Research model. FCF includes customer prepayments.
Oracle sells the database and applications that run company records, and now rents AI computing capacity. Support and licenses ($24.5bn) are sticky; infrastructure customers buy scarce GPU capacity (utilisation 97.9%, renewals about 20% higher). New backlog is mostly on prepaid or customer-hardware terms.
EBITDA of $29.9bn became free cash flow of −$23.7bn in FY26A because capex was $55.7bn. Profit by offering is not disclosed, so we value the group on a DCF.
Infrastructure supplies 92% of FY27E revenue growth, and its margin is the lever that matters most
Source: Company filings (10-K FY26); Penmark Research model. Cost of revenue and other is derived as revenue less R&D, SG&A and operating income; it includes depreciation of $9.3bn.
Operating leverage is strong in software but the cash cost of cloud is capex, not opex. R&D and SG&A together took 30 cents of each dollar. Depreciation rises from $9.3bn in FY26A to $20.0bn in FY27E and $33.7bn in FY28E in our model, so EBIT grows 4% in FY28E while EBITDA grows 30%.
Source: Penmark Research model; FY26A base. Infrastructure growth is the section 9 driver; its FY28E-FY31E path is +70%, +42%, +26%, +14%.
Source: Company filings; Penmark Research model. Year to 31 May.
Source: Company filings; Penmark Research model. Year to 31 May.
Demand for AI capacity exceeds supply, but Oracle shares the market with peers earning 19-63% margins
Source: Company filings (10-K FY26, 10-Q Note 6); FQ1 FY27 call (10 Sep 2026); Penmark Research. Customer names from company statements and press.
Source: Signals and company filings; latest reported quarter against the year-ago quarter (Peers tab, 6 Nov 2026).
Source: Signals and company filings; latest-quarter EBITDA / revenue (Peers tab, 6 Nov 2026).
Demand drivers and cycle position
Demand exceeds supply today, and the signs are in hyperscaler spending. Microsoft guides FY27 capex of about $170bn and Google is leasing outside compute at $920m a month. Management reports 97.9% GPU utilisation.
Threats
The threats are capacity churn, funding and politics. Microsoft is winding down a 2023 rental and Tencent cancelled a $7bn lease. After the 3 Nov midterms, data-center permits are a new risk (Bear 5, −$16.9 a share).
Source: Company quarterly releases; Signals KPI (cloud infrastructure revenue).
Source: FQ1 FY27 call (10 Sep 2026); Penmark Research model (Revenue build tab); our figure is total revenue, not only backlog.
Oracle pairs 30% growth with a 52% margin, and trades on the lowest EV/EBITDA of its peers (13.9x)
Source: Signals and company filings (Peers tab, 6 Nov 2026). Log scale on growth. Competitors we do not cover: CoreWeave, ServiceNow.
| Source of advantage | Rating | Evidence |
|---|---|---|
| Switching costs | ●●●● | License support of $19.8bn is flat but recurring; databases are embedded in customer systems |
| Scale | ●●●○ | $664bn backlog; 850 MW delivered in FQ1 FY27 |
| Cost position | ●●○○ | New debt at 7.00-8.65%; net debt/market value 0.24x vs 0.01x for peers |
| Customer breadth | ●●○○ | OpenAI: S&P estimates about half of the $638bn RPO (about $320bn); Oracle does not disclose it |
| Pricing power | ●●●○ | Renewals about +20% on older GPUs; utilisation 97.9% |
Source: Company filings and FQ1 FY27 call; S&P Global Ratings (OpenAI share of RPO, an external estimate); Penmark Research ratings (analyst judgement, four dots = strongest).
Source: Signals and Yahoo Finance prices (6 Nov 2026); company filings; Peers tab. Trailing four quarters.
Source: Signals and company filings; net debt / equity market value (Peers tab, 6 Nov 2026). Microsoft and Alphabet are net cash.
| Company | EV, $bn | EV/EBITDA | Revenue growth | EBITDA margin | Net debt / equity |
|---|---|---|---|---|---|
| Oracle | 473.4 | 13.9x | 29.6% | 52.1% | 0.24x |
| Microsoft | 3,884.1 | 18.9x | 18.8% | 62.9% | 0.00x |
| Amazon | 2,900.0 | 15.8x | 12.1% | 24.3% | 0.02x |
| Alphabet | 3,383.2 | 18.2x | 24.7% | 38.7% | 0.00x |
| Salesforce | 203.3 | 16.1x | 10.8% | 29.1% | 0.16x |
| CoreWeave | 55.3 | 14.7x | 112.3% | 52.5% | 1.16x |
| ServiceNow | 106.9 | 38.7x | 20.5% | 18.9% | 0.01x |
| Peer median | 17.1x | 19.7% | 33.9% | 0.02x |
Source: Signals and Yahoo Finance prices (6 Nov 2026), company filings; Penmark Research. Trailing four quarters for EV/EBITDA; growth and margin latest quarter. Oracle EV $473.4bn: 31 Aug 2026, pro forma for the 4 Nov issue, incl. finance leases and prepayments.
Management has put $97bn into capex in five years, and the FY30 plan is 28% above our base case
| Executive | Role | Recent Form 4 activity |
|---|---|---|
| Mike Sicilia | Co-CEO since 22 Sep 2025 | Disposed 22,562 shares at $151.59 ($3.4m), 22 Sep 2026 |
| Safra Catz | Executive vice chair | Tax settlement, 2,550 shares at $125.54, 23 Oct 2026 |
| Larry Ellison | Chairman and CTO | Owns 1,158m shares, 38.2% of the class (proxy, 21 Sep 2026); 413m shares are pledged as collateral, which is not a sale |
| Stephen Rusckowski | Insider | Bought 25,000 shares at $139.35 ($3.5m), 29 Sep 2026 |
Source: Oracle investor relations; SEC Form 4 filings via Signals (Sep-Oct 2026). Tax settlements are not discretionary sales.
Source: SEC Form 4 filings via Signals, 22-29 Sep 2026; $m (shares x price). Smith: 2,631 shares at $151.70.
Source: Company filings (10-K FY22-FY26); Penmark Research. Sums of FY22A-FY26A; capex $4.5bn, $8.7bn, $6.9bn, $21.2bn, $55.7bn ($97.0bn). Cerner $27.7bn (FY23); buybacks $16.2bn in FY22. Debt, cash and other is the residual.
Source: Signals KPI (non-GAAP EPS); company releases; consensus from MarketBeat for FQ1 FY27. FQ2 FY26 includes the Ampere gain.
Source: Company filings; Investor Day 28 Oct 2026 (target at least $225bn); Penmark Research model.
The stock trades on backlog, margin and funding news rather than on EPS, and the market has priced about 70% of the weighted backlog risk
The shares fell 52% in a year while earnings grew: the P/E fell from 56.4x to 18.2x. Three drivers each pass at least two of four tests. Against our probability-weighted values, the market has priced about 70% of the OpenAI backlog risk ($7.87 of $11.41), and has moved by more than our weighted values on margin and funding.
| Driver | What moves the stock | Tests confirmed | Market reaction vs our model value | Debate | Next number to watch |
|---|---|---|---|---|---|
| Backlog and OpenAI | Change in RPO; news on the largest customer | ●●●○ Event-day, call Q&A, decomposition | 8 Oct OpenAI shortfall: −$7.87 (−5.5%). Model: Bear 1 −$32.61 × 35% = −$11.41 | 1. Backlog conversion | RPO, Mar 2027: we expect conversion on the $332bn path; moves value +$24.3 or −$32.6 |
| Infrastructure margin | Lease cost and GPU pricing against the 66% run-rate | ●●●○ Event-day, call Q&A, decomposition | Investor Day 28 Oct: +$14.01 (+10.7%). Model: Bull 3 +$12.11 × 35% = +$4.24 | 2. Infrastructure margin | Margin, Dec 2026: we model 66% FY27E and 60% from FY28E |
| Funding and equity | Capital raises, debt cost and the $20bn cap | ●●●○ Event-day, call Q&A, decomposition | 2 Nov $20bn raise: −$11.45 (−8.8%). Model: Bear 4 −$13.24 × 30% = −$3.97 | 3. Cost of capital | Capex guide, Jun 2027: we model $90bn for FY28E |
Source: Signals, Yahoo Finance, earnings-call transcripts, Penmark Research model. A driver is kept only if two of four tests confirm it (filled dots = tests passed).
Source: Signals (prices, RPO), Yahoo Finance; Penmark Research. Last six results, Jun 2025 to Sep 2026.
Source: Signals (GAAP EPS, trailing four quarters), Yahoo Finance; Penmark Research. Three years to 6 Nov 2026; dividends excluded. Over one year earnings growth added $116 and the P/E took away $244 (Exhibit 21).
Source: Yahoo Finance closes (7-8 Oct, 27-28 Oct, 30 Oct-2 Nov 2026); Penmark Research model catalyst re-runs (Bear 1 at 35%, Bull 3 at 35%, Bear 4 at 30%; value per share times probability). Events are broader in scope than the model re-runs.
Rates and the EPS print do not move Oracle; the next numbers are RPO in March and infrastructure margin in December
Source: Yahoo Finance weekly returns, Nov 2024 to Nov 2026 (n=106); Penmark Research. Incremental R² of nested OLS: total 54.6%. The 10-year yield alone explains 0.8%.
Source: Signals earnings-call transcripts, six calls from Mar 2025 to Sep 2026 (19 questions coded to a topic); Penmark Research coding.
What the market does: RPO change vs next-day move has a correlation of 0.75 over six results; the 8 Oct OpenAI shortfall cost $7.87 a share. Our model: Bear 1 is worth −$32.61 and Bull 2 +$24.34 a share; at 35% each, −$11.41 and +$8.52 weighted. Gap: the market has priced 69% of the weighted Bear 1 value ($7.87 of $11.41), a gap of $3.54. Debate 1. Next: RPO in March 2027; Bull 2 +$24.3, Bear 1 −$32.6.
What the market does: Investor Day targets (40% group non-GAAP margin) lifted the shares $14.01 (+10.7%) on 28 Oct; the gain has since gone. Our model: +3pt of infrastructure margin is worth $12.11; −5pt is −$20.19. Gap: market paid $9.77 more than the weighted +$4.24; we sit at 60%, not 66%. Debate 2. Next: FQ2 FY27 margin in December 2026; we model 66% in FY27E and 60% from FY28E.
What the market does: The $20bn raise priced on 2 Nov cost $11.45 (−8.8%) in one session. Our model: +0.5pt on WACC is −$13.24; our base adds a $10.7bn funding-line draw in FY28E after the $20bn cap is used. Gap: market paid $7.48 more than the weighted −$3.97 (Bear 4 at 30%). Debate 3. Next: FY28 capex guide in June 2027; we model $90bn.
| Candidate | Test result | Verdict |
|---|---|---|
| 10-year Treasury yield | Weekly changes explain 0.8% of returns; no event-day link | Dropped |
| EPS surprise | FQ1 FY27 beat by $0.18 yet the stock fell 1.7% next day | Dropped |
| Applications and database | Most questions (5 of 19) but no price reaction on any event | Single test, dropped |
| Capacity and GPU supply | 3 of 19 questions; no event-day link | Single test, dropped |
Source: Yahoo Finance, Signals, Penmark Research. Limits: six results and 106 weeks are small samples; correlations are descriptive, and the FQ1 FY26 move (+36%) drives the fit.
Source: Penmark Research model re-runs (Sensitivities tab, 6 Nov 2026); base-case value per share at the price date.
Backlog converts below the management path: FY30E revenue $175bn against the $225bn target
What the market believes
Street FY28E revenue is $131.8bn and FY30E $224.2bn (LSEG); the target is reaffirmed. At $116.10 the price implies a 9.98% WACC, so it already discounts some risk.
What it is worth
FY28E infrastructure revenue $66.7bn against about $79bn implied by the Street: FY28E non-GAAP EPS $8.29 against $11.05. Our 36-month revenue of $383bn is 1.15x the backlog expected to convert. Value: +$24.34 if it converts on time, −$32.61 if OpenAI cannot fund its ramp.
The evidence, from three sources
- 1. Reported data. RPO rose from $138bn to $664bn in six quarters; the quarterly increase has slowed from $317bn to $26bn. Management expects about half ($332bn) to convert in 36 months.
- 2. Call statements. Backlog, OpenAI and customers were 3 of 19 analyst questions; new RPO is mostly on prepaid or customer-hardware terms, with no capex or revenue effect before FY28 (call, 10 Sep 2026).
- 3. Industry and news. S&P Global Ratings estimates roughly half of the $638bn RPO reported at 31 May (about $320bn) is linked to OpenAI, an external estimate as Oracle does not disclose RPO by customer. OpenAI annualised revenue about $20bn below investor estimates (8 Oct); Microsoft is winding down a 2023 rental and Tencent cancelled a $7bn lease (5-6 Nov).
Source: Company quarterly releases; Signals KPI (cloud infrastructure revenue); growth against the year-ago quarter.
Source: Penmark Research model catalyst re-runs (Sensitivities tab); $ per share against the $120.46 base.
Signposts (rests on driver: RPO change on results day)
| Date | Event | Confirms / disproves |
|---|---|---|
| Dec 2026 | FQ2 FY27: infrastructure growth | Above +116% for FY27E confirms; below +100% breaks |
| Mar 2027 | FQ3 FY27 RPO update | Above $664bn on prepaid terms confirms Bull 2; a cut breaks |
| Jun 2027 | FY28 capex guide | Above $100bn without new prepaid contracts disproves |
Leases hold infrastructure margin near 60%, and each point is worth $4.04 a share
What the market believes
The Street models about a 66% infrastructure margin (the FQ1 FY27 run-rate) and a 40% group non-GAAP margin by FY30. The price implies 58.9% FY30E, close to our 60.0%.
What it is worth
One point of infrastructure margin is worth $4.04 a share. At 60% we are 6pt below the run-rate; EBIT margin falls from 33.1% to 26.1% in FY28E as D&A reaches $33.7bn. Value: +$12.11 at +3pt, −$20.19 at −5pt.
The evidence, from three sources
- 1. Filings. $288bn of data-center leases commence between FQ2 FY27 and FY29 (10-Q Note 6); FQ1 FY27 capex was $28.5bn and D&A $3.4bn.
- 2. Call statements. Management guided a gross margin step-down in FY27, flattening over the next couple of years; margin and cost to serve was 4 of 19 questions.
- 3. Peers. CoreWeave, the closest pure play, earns a 52.5% EBITDA margin; Oracle's quarter is 52.1% and group margin of 55.3% in FY27E is already above FY26A's 44.4%.
Source: Company quarterly filings; Signals; Penmark Research (operating income plus D&A, over revenue).
Source: Penmark Research model re-runs (Sensitivities tab); value per share at the price date.
Signposts (rests on driver: Lease cost and GPU pricing)
| Date | Event | Confirms / disproves |
|---|---|---|
| Dec 2026 | FQ2 FY27 EBITDA margin | Above 55% with D&A rising confirms +3pt; a fall below 50% disproves |
| FY27-FY28 | Lease commencement and gross margin | Margin at 55% equals Bear 3 (52% is the full bear case) |
| Jan-Feb 2027 | Hyperscaler results | Sustained capex keeps GPU pricing (renewals +20%) |
The discount rate decides the call: each point of WACC moves value $27.76 a share
What the market believes
The Street is not debating funding: it assumes the $20bn capital cap (about half equity) is enough and net debt/EBITDA stays below 3.5x. The price implies a 9.98% WACC against our 9.82%.
What it is worth
WACC −1pt gives a $159.89 target (+37.7%, Buy); +1pt gives $99.09 (−14.7%, Sell), each rolled 12 months from the weighted value ($146.02 and $90.49). Net debt/EBITDA peaks at 3.3x in FY26A and falls to 1.6x by FY29E in our model. Value: −$13.24 for +0.5pt of WACC.
The evidence, from three sources
- 1. Filings and prospectus. Notes priced on 2 Nov at 7.00-8.65%, spreads +145-175bp wider than in February; $29.8bn of equity issued; net debt $97.6bn at May 2026.
- 2. Ratings and calls. S&P lowered Oracle to BBB- on 9 Jul; Moody's affirmed Baa2 with a negative outlook on the new notes; capex and funding was 4 of 19 analyst questions, the second most.
- 3. Our model. Cash held at $15bn needs a $10.7bn funding-line draw in FY28E; the $20bn capital-markets cap was used in full by the notes and shares priced on 2 Nov (closed 4 Nov), so we assume the draw comes from the credit line and commercial paper (about $19.7bn of headroom), not new issuance.
Source: Penmark Research model (Scenarios tab); terminal growth 3.0%, value per share at the price date. The price implies a 9.98% WACC.
Source: Company filings; Penmark Research model. Includes customer prepayments of $22.5bn in FY27E, $10.0bn in FY28E and $5.0bn in FY29E.
Signposts (rests on driver: Rates and funding cost)
| Date | Event | Confirms / disproves |
|---|---|---|
| 1H 2027 | Moody's and S&P rating reviews | Moody's to Baa3 or S&P to BB+ disproves; a stable outlook confirms |
| Jun 2027 | FY28 capex guide and funding plan | Capex at $90bn with prepayments of $10bn confirms |
| Any time | Second equity raise | Any raise beyond the 4 Nov issue breaks the base case |
Revenue and EPS have compounded for four years, but profit stopped converting to cash in FY25A
| Year to 31 May | FY22A | FY23A | FY24A | FY25A | FY26A |
|---|---|---|---|---|---|
| Revenue ($bn) | 42.4 | 50.0 | 53.0 | 57.4 | 67.4 |
| Growth y/y | n/a | 17.7% | 6.0% | 8.4% | 17.4% |
| EBITDA ($bn) | 14.0 | 19.2 | 21.5 | 23.9 | 29.9 |
| EBITDA margin | 33.1% | 38.4% | 40.6% | 41.6% | 44.4% |
| Operating margin | 25.7% | 26.2% | 29.0% | 30.8% | 30.6% |
| Net income ($bn) | 6.7 | 8.5 | 10.5 | 12.4 | 17.1 |
| EPS, GAAP ($) | 2.41 | 3.07 | 3.71 | 4.34 | 5.83 |
| Operating cash flow ($bn) | 9.5 | 17.2 | 18.7 | 20.8 | 32.0 |
| Capex ($bn) | 4.5 | 8.7 | 6.9 | 21.2 | 55.7 |
| Free cash flow ($bn) | 5.0 | 8.5 | 11.8 | (0.4) | (23.7) |
| Stock compensation ($bn) | 2.6 | 3.5 | 4.0 | 4.7 | 4.8 |
| FCF / net income | 0.75x | 1.00x | 1.13x | n/m | n/m |
Source: Company filings (10-K FY22-FY26); Penmark Research model. GAAP; FCF = operating cash flow less capex.
Source: Company releases; Signals (diluted EPS and non-GAAP KPI). FQ2 FY26 GAAP EPS includes the Ampere gain.
Source: Company filings (10-K FY22-FY26); Penmark Research.
Accounting choices that flatter results
Stock compensation and leases are the two to watch. Non-GAAP EPS excludes stock compensation ($4.8bn in FY26A, 7.1% of revenue) and amortization; we treat it as a cash cost in the DCF. Operating lease cost sits in EBITDA, but $288bn of leases have not yet commenced.
Profit-to-cash conversion
Reported profit no longer converts to cash. FCF was 113% of net income in FY24A and −139% in FY26A. Customer prepayments ($4.6bn in FY26A, $11.4bn in FQ1 FY27 alone) are financing, not operating cash, in our model.
Our forecasts match FY27 guidance, but FY30E revenue is 22% and EPS 32% below the Investor Day targets
Source: Penmark Research model (driver tree as Exhibit 32). Infrastructure growth FY28E-FY31E: +70%, +42%, +26%, +14%.
| Metric | Guidance | Penmark | Gap | Status |
|---|---|---|---|---|
| Revenue, FY27 ($bn) | 90.0 floor | 90.2 | +0.2% | Inside range |
| Non-GAAP EPS, FY27 ($) | 8.10 | 8.11 | +0.1% | Inside range |
| Capex, FY27 ($bn) | 90-95 | 92.5 | mid | Inside range |
| Revenue, FY30 ($bn) | 225+ | 175.3 | −22.1% | Outside |
| Non-GAAP op. margin, FY30 | 40%+ | 36.7% | −3.3pp | Outside |
| Non-GAAP EPS, FY30 ($) | 21.00+ | 14.36 | −31.6% | Outside |
| FCF, FY29 ($bn) | 30+ | 6.7 | −77.8% | Outside |
| Net debt / EBITDA, FY29 | <3.5x | 1.6x | below cap | Inside range |
| Funding-line draw FY28E ($bn) | 20 new-capital cap used | 10.7 | beyond cap | Outside |
Source: Company FQ1 FY27 call (10 Sep 2026) and Investor Day (28 Oct 2026, 8-K Ex 99.1); Penmark Research model. Reasons: OpenAI concentration, lease costs ahead of revenue, D&A on $182bn of capex.
Source: S&P Global via StockAnalysis (6 Nov 2026); Penmark Research model. EPS is non-GAAP.
Source: Penmark Research model re-runs (Sensitivities tab); base-case value per share.
Costs, cash and balance sheet
D&A, not opex, is the cost that scales. We hold the software margin at 47% and set infrastructure margin at 66% in FY27E and 60% after. Capex is $92.5bn, $90.0bn and $65.0bn in FY27E-FY29E, with prepayments of $22.5bn, $10.0bn and $5.0bn.
What the model needs
Cash is held at a $15bn minimum. That needs a $10.7bn draw in FY28E on the credit line and commercial paper, which is outside the $20bn new-capital cap; net debt peaks at $130.2bn and falls to 1.6x EBITDA by FY29E.
The target of $125 rests on a DCF worth $120.46, cross-checked by a peer multiple at $152.52
Method one: ten-year DCF
A DCF fits because FY27-FY28 capex of $182bn exceeds EBITDA. Free cash flow to the firm to FY36, mid-period, at a 9.82% WACC (risk-free 4.84%, equity premium 5.0%, beta 1.28, cost of debt 8.0%). Terminal growth is 3.0% on 12% return on new capital; terminal value is 68% of EV. Stock compensation is a cash cost; prepayments are financing.
Method two: peer EV/EBITDA
The cross-check gives $152.52, 26.6% above the DCF. Peer median 17.1x on Oracle's trailing EBITDA of $33.9bn. It sits higher because trailing EBITDA does not charge $182bn of FY27-FY28 capex or the funding it needs. We reject sum-of-the-parts (no segment capex disclosure) and forward P/E (D&A timing).
Source: Penmark Research model (Valuation tab), 31 Aug 2026. Other claims: prepayments $16.0bn, minorities and preferred $1.2bn. Equity value $366.9bn over 3,089m shares is $118.78, rolled to $120.46 at 6 Nov 2026 on 3,175m shares after the 4 Nov issue.
Source: Penmark Research model (Valuation tab); value per share at the 6 Nov 2026 price date, target rolled 12 months at 9.5%.
Source: Penmark Research model (Scenarios tab); base case at the price date.
Source: Penmark Research model (Sensitivities tab); each driver solved alone to $116.10, others at base.
Bear, base and bull cases tie to the drivers, and the weighted value of $114 supports a Hold
Source: Penmark Research model (Scenarios tab). Probabilities are analyst assumptions; bear: infrastructure margin 52%, FY30E revenue $118bn; bull: management plan, margin 66%, $226bn.
Source: Penmark Research model catalyst re-runs (Sensitivities tab); $ per share against base $120.46.
| US$bn at 31 Aug 2026 | Value |
|---|---|
| PV of FY27-FY36 cash flows | 154.1 |
| PV of terminal value (68% of EV) | 327.4 |
| Enterprise value | 481.5 |
| Borrowings | (125.3) |
| Finance leases | (9.2) |
| Cash and marketable securities | 37.1 |
| Customer prepayments received | (16.0) |
| Minorities and preferred dividends | (1.2) |
| Equity value | 366.9 |
| Value per share at 31 Aug ($) | 118.78 |
| Rolled to 6 Nov 2026, 3,175m shares ($) | 120.46 |
Source: Penmark Research model (Valuation tab).
Source: S&P Global via StockAnalysis (42 analysts, 6 Nov 2026); Penmark Research model.
Five dated events decide the rating, and two of them can add $24 or remove $33 a share
Source: Company calendar; Penmark Research. Results dates are estimates until confirmed.
| Date | Event | What decides it | Consensus | Penmark |
|---|---|---|---|---|
| Dec 2026 | FQ2 FY27 results | Infra revenue +116% FY27E; revenue growth +30-34% guide; EPS $1.85-1.93 guide | FY27E revenue $90.45bn, EPS $8.14 | $90.2bn, $8.11 |
| Jan-Feb 2027 | Hyperscaler CQ4 results | Capex stays high; compute scarce (Bull 5, +$14.5) | Partly priced | Not in base |
| Mar 2027 | FQ3 FY27 RPO update | RPO above $664bn on prepaid terms (Bull 2, +$24.3) or OpenAI cut (Bear 1, −$32.6) | FY28E revenue $131.8bn | $119.3bn |
| 1H 2027 | Moody's and S&P reviews | Moody's Baa2, negative outlook (affirmed on the new notes); S&P cut to BBB- on 9 Jul; a further cut adds funding cost (Bear 4, −$13.2 per +0.5pt) | Priced in bond spreads | WACC 9.82% |
| Jun 2027 | FY28 capex guide | $90bn FY28E; $15bn lower in FY29 is +$4.5 (Bull 4) | FY27E FCF −$34.7bn (company basis) | −$25.1bn |
Source: Company guidance (10 Sep, 28 Oct 2026); S&P Global via StockAnalysis (6 Nov 2026); Penmark Research model catalyst re-runs. Events that could change the rating: the March RPO update and a rating cut.
Source: Signals and Yahoo Finance closes, 28 Oct to 6 Nov 2026.
Four risks cost $13-33 a share, and the thesis ends if the March RPO update shows a cut or a conversion
| Risk | What happens | Likelihood | Value per share | Signpost |
|---|---|---|---|---|
| OpenAI concentration | Largest customer cannot fund its ramp; commitments renegotiated | 35% | −$32.61 | RPO and OpenAI terms, Mar 2027 |
| Leases ahead of revenue | $288bn of leases commence by FY29; infrastructure margin 55% not 60% | 40% | −$20.19 | FQ2 FY27 margin, Dec 2026 |
| Political backlash | Post-midterm limits slow new data-center capacity | 30% | −$16.86 | State permits, from Jan 2027 |
| Funding cost | Notes at 7.00-8.65%; Moody's to Baa3 or S&P to BB+; WACC +0.5pt | 30% | −$13.24 | Rating reviews, 1H 2027 |
| Upside risk to our Hold | RPO converts on schedule on prepaid terms (Bull 2) | 35% | +$24.34 | RPO, Mar 2027 |
Source: Penmark Research model catalyst re-runs (Sensitivities tab); likelihoods are analyst assumptions (Thesis tab). Value per share against the $120.46 base.
Source: Penmark Research model (Thesis, Sensitivities tabs). Likelihoods are analyst assumptions.
Source: Penmark Research model (Thesis tab): $24.34 x 35% and −$32.61 x 35%. Weighted contributions are arithmetic on those inputs.
Source: Penmark Research model (Sensitivities tab, 6 Nov 2026); 12-month target per share (probability-weighted value rolled at 9.5%). Upside to target: Buy above +10%, Sell below −10%, against the $116.10 price.
What would end the thesis
The March 2027 RPO update is the one number that matters. Base-case value is near $145 if commitments hold (Bull 2) and near $88 on a cut (Bear 1).
Regulatory, legal and key-person
Control and politics matter most. Larry Ellison (chairman, CTO) owns 38.2% of the shares, with 413m pledged as collateral (proxy, 21 Sep 2026). Data-center permits after the 3 Nov midterms are the main regulatory risk.
Institutions hold at least 42% of Oracle, short interest is 1.6%, and the Street is 83% Buy
Source: SEC 13F filings via Signals, 30 Jun 2026; shares in millions. 13F filers report 1,280m shares, 42.3% of shares outstanding.
Source: FINRA short interest via Signals, settlement dates 29 May to 15 Oct 2026. Days to cover: 1.88, 1.38, 1.40, 2.32, 1.47, 1.66.
Source: S&P Global via StockAnalysis, 42 analysts, 6 Nov 2026. Penmark Research rating is Hold.
Source: S&P Global via StockAnalysis, 6 Nov 2026 (42 analysts); Penmark Research model. Percent change from the $116.10 price to each target.
| Liquidity and positioning | Value |
|---|---|
| Share price, 6 Nov 2026 ($) | 116.10 |
| 52-week range, close ($) | 114.99 - 248.15 |
| Average daily value traded, 3 months ($bn) | 4.6 |
| Shares outstanding, 30 Jun 2026 (m) | 3,024 |
| Short interest, 15 Oct 2026 (m shares) | 47.5 |
| Days to cover | 1.66 |
| 13F coverage of shares outstanding | 42.3% |
Source: Yahoo Finance (price, volume); Signals (13F, short interest). Value traded is the three-month average of close x volume.
Insiders and control
Insider activity is mixed, not bearish. Stephen Rusckowski bought 25,000 shares ($3.5m) at $139.35 on 29 Sep 2026; Mike Sicilia sold 22,562 ($3.4m) on 22 Sep. Larry Ellison, chairman and CTO, owned 1,158m shares (38.2% of the class) at 21 Sep 2026 per the proxy; 413m of them are pledged as collateral, which is not a sale.
Overhangs
New supply is the overhang. Oracle sold $19.9bn of stock through its at-the-market programme in FQ1 FY27 and $9.9bn net (86.2m shares at about $116; priced 2 Nov, closed 4 Nov 2026). The mandatory convertible preferred adds up to 31.2m shares. Our base case assumes no further equity.
The model builds to $175bn of revenue and $29bn of free cash flow in FY30E, after two years of negative cash flow
| US$bn, year to 31 May | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 57.4 | 67.4 | 90.2 | 119.3 | 149.1 | 175.3 |
| Growth y/y | 8.4% | 17.4% | 33.9% | 32.3% | 24.9% | 17.6% |
| EBITDA | 23.9 | 29.9 | 49.8 | 64.8 | 82.4 | 97.9 |
| EBITDA margin | 41.6% | 44.4% | 55.3% | 54.3% | 55.3% | 55.8% |
| EBIT | 17.7 | 20.6 | 29.8 | 31.1 | 42.2 | 55.1 |
| Net income | 12.4 | 17.1 | 20.5 | 20.7 | 28.1 | 38.4 |
| EPS, GAAP ($) | 4.34 | 5.83 | 6.52 | 6.43 | 8.77 | 12.08 |
| EPS, non-GAAP ($) | n/a | 7.63 | 8.11 | 8.29 | 10.88 | 14.36 |
| Cash flow | ||||||
| Operating cash flow | 20.8 | 32.0 | 67.4 | 65.7 | 71.7 | 81.6 |
| Capex | 21.2 | 55.7 | 92.5 | 90.0 | 65.0 | 52.6 |
| Free cash flow, company basis | (0.4) | (23.7) | (25.1) | (24.3) | 6.7 | 29.0 |
| Stock compensation | 4.7 | 4.8 | 5.2 | 6.6 | 7.8 | 8.8 |
| Balance sheet | ||||||
| Net debt, ex finance leases | 81.4 | 97.6 | 99.4 | 130.2 | 130.1 | 107.6 |
| Net debt / EBITDA, ex leases | 3.4x | 3.3x | 2.0x | 2.0x | 1.6x | 1.1x |
| Total equity | 21.0 | 43.1 | 92.4 | 113.5 | 143.2 | 184.2 |
| US$bn, year to 31 May | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|
| Capital and funding | ||||||
| Capex | 21.2 | 55.7 | 92.5 | 90.0 | 65.0 | 52.6 |
| Customer prepayments (model) | n/a | 4.6 | 22.5 | 10.0 | 5.0 | n/a |
| Dividends paid | 4.7 | 5.8 | 6.1 | 6.2 | 6.2 | 6.6 |
| Common equity issued | n/a | n/a | 29.8 | 0.0 | 0.0 | 0.0 |
| Funding line drawn | n/a | n/a | 0.0 | 10.7 | 0.0 | 0.0 |
| US$bn, year to 31 May | FY25A | FY26A | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|
| Cloud infrastructure | ||||||
| Infrastructure revenue | 10.2 | 18.1 | 39.2 | 66.7 | 94.6 | 119.3 |
| Growth y/y | n/a | 76.9% | 116.6% | 70.0% | 42.0% | 26.0% |
| Share of revenue | 17.8% | 26.9% | 43.5% | 55.8% | 63.5% | 68.0% |
| Rest of Oracle | ||||||
| Other revenue | 47.2 | 49.3 | 51.0 | 52.7 | 54.4 | 56.1 |
| Growth y/y | n/a | 4.4% | 3.5% | 3.4% | 3.3% | 3.1% |
| Backlog at 31 Aug 2026 | ||||||
| Remaining performance obligations ($bn) | n/a | n/a | 664 | n/a | n/a | n/a |
| Converting within 36 months ($bn) | n/a | n/a | 332 | n/a | n/a | n/a |
Source: Company filings (10-K, 10-Q); Penmark Research model. Revenue from Sep 2026 to Aug 2029 in the model is $383.1bn, 1.15x the $332bn converting. Free cash flow is company basis, including customer prepayments.
Reference: adjusted EPS runs $0.36-1.80 above GAAP, and every figure comes from one model dated 6 November 2026
| Per share ($) | FY26A | FQ1 FY27 |
|---|---|---|
| GAAP diluted EPS | 5.83 | 1.56 |
| Non-GAAP diluted EPS | 7.63 | 1.92 |
| Difference | 1.80 | 0.36 |
Source: Company releases; Signals (GAAP diluted EPS, non-GAAP KPI). FQ2 FY26 GAAP EPS of $2.10 includes the Ampere gain.
| ROE | Net income to common over average common equity. |
| ROA | Net income over average total assets. |
| ROCE | EBIT over average equity plus borrowings. |
| Net debt | Borrowings less cash and marketable securities in the statement tables; the stock-data figure ($87.5bn at 31 Aug 2026, pro forma for the 4 Nov issue) also includes $9.2bn of finance leases. |
| EBITDA | Operating income plus depreciation and amortization. |
| P/E at target | $124.99 target over the fiscal-year EPS shown. |
| FCF yield | Company-basis FCF over market value at $116.10. |
Source: Penmark Research model (Methodology tab).
| RPO | Remaining performance obligations: contracted revenue not yet recognised ($664bn at 31 Aug 2026). |
| Infrastructure | Oracle Cloud Infrastructure: compute, storage and network sold for AI training and general workloads. |
| Prepayments | Cash customers pay ahead of delivery for capacity. We treat them as financing, not operating cash. |
| FCF, company basis | Operating cash flow less capex, including customer prepayments. Ex-prepayments basis strips them out. |
| WACC | Weighted average cost of capital; 9.82% in our model. |
| Lease commencement | Date a leased data center starts generating lease cost; $288bn of leases have not yet commenced. |
Source: Company filings; Penmark Research definitions.
Methodology note
Archetype: capacity and utilisation, with a projects and backlog element. The primary method is a ten-year FCFF DCF valued at 31 Aug 2026 and rolled to 6 Nov 2026; the cross-check is peer median trailing EV/EBITDA. We reject sum-of-the-parts (no segment capex disclosure) and forward P/E as primary. Rating: Hold on upside to the 12-month target of +7.7% (probability-weighted value of $114.14 rolled 12 months at 9.5%), excluding dividends.
Peer set and data sources
Six peers: Microsoft, Amazon, Alphabet, Salesforce, CoreWeave and ServiceNow, chosen for cloud infrastructure and enterprise software exposure; median trailing EV/EBITDA 17.1x. Sources, as of 6 Nov 2026: company filings and calls (through FQ1 FY27, 10 Sep 2026; Investor Day 28 Oct 2026); Signals (filings, 13F, Form 4, FINRA short interest, transcripts); Yahoo Finance (prices); S&P Global via StockAnalysis (consensus, Street targets); Penmark Research model.
Analyst certification and important disclosures
Ratings
Ratings are based on the upside from the share price to our 12-month price target, excluding dividends. The price target is weighted across bull, base and bear scenarios.
| Buy | Upside to price target above +10% |
| Hold | Upside to price target between −10% and +10% |
| Sell | Upside to price target below −10% |
We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.
Analyst certification
The Penmark Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.
Contact
Penmark Research
Questions about our research:
research@penmarkresearch.com
All our research and coverage:
penmarkresearch.com
Basis of preparation
This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.
Valuation and price targets
Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.
Independence and conflicts of interest
Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.
No member of the Penmark Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.
Regulatory status
Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.
Not investment advice or an offer
This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.
Forward-looking statements and risk
Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.
Data and sources
Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.
Accuracy and liability
Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.
Distribution and access
Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.
Copyright and permitted use
© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.